US7044911B2
Expired / Lapsed
US
⏱️ 0.0 years remaining
Gateway platform for biological monitoring and delivery of therapeutic compounds
Assignee: Philometron Inc
•
Filing: 2001-10-29
•
Granted: 2006-05-16
•
Expires: 2021-10-29
Abstract
Abstract The invention relates to methods and devices for remote or distributed continuous monitoring of physiologically relevant states. The invention provides for methods to automatically detect deviations or other states in physiological parameters and automatically alert a measured subject, user or other authorized party. The device provides for a universal platform for sensors, and further provides for the automatic compensation or distribution of devices or bioactive agents at appropriate levels and/or intervals in response to deviations or other states sensed in various physiological parameters.
Inventors
- 👤 Darrel Drinan
- 👤 Carl F. Edman
- 👤 Diethard Merz
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 15:50
CPC Classifications
G; G16; G16H; G16H20/00; G16H20/10; G16H20/13; A; A61; A61B; A61B5/00; A61B5/0002; A61B5/0015; A61B5/0022; A61B5/145; A61B5/14539; A61B5/24; A61B5/41; A61B5/411; A61B5/48; A61B5/4836; A61B5/4839; A61B5/486; G16H40/00; G16H40/60; G16H40/63; G16H40/67; A61B2560/00; A61B2560/02; A61B2560/0266; A61B2560/0271; A61B5/02; A61B5/08; A61B5/082; A61M; A61M5/00; A61M5/14; A61M5/168; A61M5/172; A61M5/1723; A61M2005/1726; A61M2205/00; A61M2205/35; A61M2205/3507; A61M2205/3523; A61M2205/3546; A61M2205/3569; A61M5/142; A61M5/14244; A61M5/14276; G16H10/00; G16H10/60; Y; Y02; Y02A; Y02A90/00; Y02A90/10; Y10; Y10S; Y10S128/00; Y10S128/903; Y10S128/904
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
153 words
A system for monitoring physiological status of a mammalian subject, comprising: a. one or more biointerface heads (BIH), each comprising one or both of a sensor for measuring a physiological parameter and a device for therapeutic compound delivery, at least one of said biointerface heads being implanted subdermally and configured to communicate data and a BIH identifier; b. at least one control and communication module (CCM) attached to an external surface of said subject and storing a CCM identifier and which is linked to at least one biointerface head to receive said data and said BIH identifier, wherein said control and communication module processes data from at least one biointerface head; c. at least one data collection unit (DCU) which receives data and said identifiers from the control and communication module; and d. a remote database management system which receives data from the at least one data collection unit and processes said data.
Claim 2
Independent Claim
153 words
A system for monitoring physiological status of a mammalian subject, comprising: a. one or more biointerface heads (BIH), each comprising one or both of a sensor for measuring a physiological parameter and a device for therapeutic compound delivery, at least one of said biointerface heads being implanted subdermally and configured to communicate data and a BIH identifier; b. at least one control and communication module (CCM) attached to an external surface of said subject and storing a CCM identifier and which is linked to at least one biointerface head to receive said data and said BIH identifier, wherein said control and communication module processes data from at least one biointerface head; c. at least one data collection unit (DCU) which receives data and said identifiers from the control and communication module; and d. a remote database management system which receives data from the at least one data collection unit and processes said data.
Claim 3
Dependent Claim
21 words
The system of claim 1 , wherein said biointerface head is attached to said mammalian subject with at least one adhesive.
Claim 4
Dependent Claim
42 words
The system of claim 2 , wherein said adhesive contains one or more of the groups comprising: growth factors, adherence molecules, adherence attractants or factors which promote cutaneous wound-healing mechanisms and formation of an epithelial-like structure around a portion of said system.
Claim 5
Dependent Claim
33 words
The system of claim 1 , wherein said system comprises a transdermal conduit and a biofluid access port, and wherein the transdermal conduit and biofluid access port are coated with a hydrogel material.
Claim 6
Independent Claim
18 words
The system of claims 4 , wherein the hycirogel material contains preservatives, anti-inflammatory agents, antibiotics or antimicrobial agents.
Claim 7
Independent Claim
21 words
The system of claims 4 , wherein the hydrogel material contains a chemical, compound or molecule for calibration of the sensor.
Claim 8
Dependent Claim
22 words
The system of claim 4 , wherein the transdermal conduit comprises a fluid material containing preservatives, anti-inflammatory agents, antibiotics or antimicrobial agents.
Claim 9
Dependent Claim
19 words
The system of claim 1 , wherein said system comprises a chamber which releases one or more therapeutic agents.
Claim 10
Independent Claim
163 words
A system comprising: a subdermal physiological parameter sensor to measure a physiological parameter of a mammalian subject and to generate measurement information based on the measurements; a mounting structure that anchors said system to a dermal layer; a flexible transdermal conduit attached to said mounting structure at or near a first end, wherein said transdermal conduit is in contact with a sensor assembly; a sensor mounting head, wherein said sensor mounting head is attached to a second end of said transdermal conduit; a biofluid access port within said sensor mounting head, the biofluid access port further comprising microstructures allowing biofluid flow into the transdermal conduit to contact the sensor assembly and block transmission of external pathogens into a subject; a control and communication module in data communication with the physiological parameter sensor to receive the measurement information from the physiological parameter sensor, the control and communication module including signal processing circuitry to generate and transmit a first signal based on the measurement information.
Claim 11
Independent Claim
163 words
A system comprising: a subdermal physiological parameter sensor to measure a physiological parameter of a mammalian subject and to generate measurement information based on the measurements; a mounting structure that anchors said system to a dermal layer; a flexible transdermal conduit attached to said mounting structure at or near a first end, wherein said transdermal conduit is in contact with a sensor assembly; a sensor mounting head, wherein said sensor mounting head is attached to a second end of said transdermal conduit; a biofluid access port within said sensor mounting head, the biofluid access port further comprising microstructures allowing biofluid flow into the transdermal conduit to contact the sensor assembly and block transmission of external pathogens into a subject; a control and communication module in data communication with the physiological parameter sensor to receive the measurement information from the physiological parameter sensor, the control and communication module including signal processing circuitry to generate and transmit a first signal based on the measurement information.
Claim 12
Dependent Claim
24 words
The system of claim 9 , wherein the control and communication module further comprises signal encryption circuitry to encrypt the first signal for transmission.
Claim 13
Dependent Claim
21 words
The system of claim 9 , wherein said mounting structure is attached to said mammalian subject with at least one adhesive.
Claim 14
Dependent Claim
40 words
The system of claim 11 , wherein said adhesive contains one or more of the groups comprising: growth factors, adherence molecules, adherence attractants or factors which promote cutaneous wound-healing mechanisms and formation of an epithelial-like structure around the mounting structure.
References Cited (Backward Citations)
US4402694A
Cited
US4854328A
Cited
US5511553A
Cited
US5242415A
Cited
US5375604A
Cited
US5558638A
Cited
US5779630A
Cited
US5445008A
Cited
US6083248A
Cited
US5752976A
Cited
US6213942B1
Cited
US5833603A
Cited
US5987352A
Cited
US6198394B1
Cited
US6225901B1
Cited
WO1998040009A1
Cited
US6016686A
Cited
US6175752B1
Cited
US6540672B1
Cited
US6360888B1
Cited
WO2000054237A1
Cited
US6092530A
Cited
US6287252B1
Cited
WO2001037726A1
Cited
US6459917B1
Cited
US6645142B2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2009-05-15 | 2009-11-14 | 2010-05-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2013-05-15 | 2013-11-14 | 2014-05-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2017-05-15 | 2017-11-14 | 2018-05-16 | $7700.00 | Window Closed / Lapsed |